Cargando…
BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
BACKGROUND: The incidence of brain metastases (BM) is tenfold higher than that of primary brain tumours. BM predominantly originate from primary lung, breast, and melanoma tumours with a 90% mortality rate within one year of diagnosis, posing a large unmet clinical need to identify novel therapies a...
Autores principales: | Kieliszek, Agata, Bassey-Archibong, Blessing, Venugopal, Chitra, Singh, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351269/ http://dx.doi.org/10.1093/noajnl/vdab071.018 |
Ejemplares similares
-
BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
por: Singh, Sheila, et al.
Publicado: (2019) -
39. CHARACTERIZING NOVEL INHIBITORS OF BRAIN METASTASIS-INITIATING CELLS
por: Kieliszek, Agata, et al.
Publicado: (2020) -
BSCI-22 DETERMINING THE EFFECT OF NOVEL SMALL MOLECULE DRUGS AGAINST THE MIGRATION OF BRAIN METASTASIS INITIATING CELLS (BMICS)
por: Mobilio, Daniel, et al.
Publicado: (2022) -
BSCI-18. Identifying novel drivers of lung-to-brain metastasis through in vivo functional genomics
por: Aghaei, Nikoo, et al.
Publicado: (2021) -
47. UNCOVERING A NOVEL ROLE FOR HLA-G IN BRAIN METASTASES
por: Bassey-Archibong, Blessing, et al.
Publicado: (2020)